Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo. Journal of Pakistan Association of Dermatologists, [S. l.], v. 20, n. 2, p. 89–92, 2016. DOI: 10.66344/jpad.v20i2.427. Disponível em: https://www.jpad.com.pk/index.php/jpad/article/view/427. Acesso em: 24 jul. 2026.